Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 141-150 of 1757 for

Edit search filters
  1. Rose Geranium In Sesame Oil Nasal Spray For The Improvement Of Nasal Vestibulitis Symptoms In Cancer Patients Receiving Chemotherapy

    Albert Lea, MN, Mankato, MN, Rochester, MN

  2. Idasanutlin, Ixazomib Citrate, And Dexamethasone In Treating Patients With Relapsed Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  3. A Study Of Ovarian Tissue Freezing For The Preservation Of Fertility In Children

    Rochester, MN

  4. A Study Of Four-Dimensional MRI For Image-Guided Radiation Therapy

    Scottsdale/Phoenix, AZ

  5. A Consortium Trial To Evaluate Proton Vs. Photon Therapy For Patients With Non-metastatic Breast Cancer

    Jacksonville, FL

  6. Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

    Rochester, MN

  7. S0820, Adenoma and Second Primary Prevention Trial

    Rochester, MN

  8. A Study To Assess The Safety And Tolerability Of CFT7455 In Relapsed/Refractory Non-Hodgkin's Lymphoma Or Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. A Study To Evaluate CC-96191 To Treat Participants With Relapsed Or Refractory Acute Myeloid Leukemia

    Jacksonville, FL, Rochester, MN

  10. Futibatinib And Pembrolizumab For The Treatment Of Advanced Or Metastatic FGF19 Positive BCLC Stage A, B, Or C Liver Cancer

    Rochester, MN

.

Mayo Clinic Footer